What is the appropriate intramuscular (IM) dose of haloperidol for an adult with moderate agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IM Haloperidol Dosing for Moderate Agitation

For an adult with moderate agitation, administer haloperidol 5 mg intramuscularly as the initial dose. This is the standard dose supported by both FDA labeling and clinical guidelines 1, 2.

Dosing Algorithm

Initial Dose

  • Standard adult dose: 5 mg IM for moderately severe to very severe symptoms 1
  • Lower dose (2 mg IM): Consider for debilitated, geriatric patients, or those with history of adverse reactions to antipsychotics 1

Repeat Dosing

  • May repeat as often as every hour based on clinical response 1
  • More commonly, 4-8 hour intervals are satisfactory 1
  • The evidence base consistently references 5 mg doses across multiple comparative trials 2

Evidence Quality and Context

The 5 mg dose is well-established through decades of research. Haloperidol has by far the best evidence base among conventional antipsychotics for treating agitation, with 20 double-blind studies since 1973 supporting its use 2. Multiple Class II studies compared 5 mg haloperidol doses to 2-4 mg lorazepam, demonstrating equivalent efficacy 2.

Important Caveats

Avoid higher doses than necessary. While some studies used 7.5 mg haloperidol, this higher dose was associated with increased extrapyramidal symptoms (6-7% incidence) compared to lower doses 3. The FDA label specifically recommends 2-5 mg for prompt control 1.

For older adults (≥65 years): Recent evidence suggests low-dose haloperidol (≤0.5 mg) may be as effective and safer than higher doses for mild-to-moderate agitation, with no difference in treatment failure rates 4. Reserve standard 5 mg doses for severe agitation in this population.

Safety Considerations

  • QTc prolongation: All antipsychotics prolong QTc interval, though typically not exceeding 500 ms at recommended doses 2
  • Extrapyramidal symptoms: Occur in approximately 1-6% of patients depending on dose 3
  • Anticholinergic toxicity: Avoid haloperidol in agitation from anticholinergic or sympathomimetic drug ingestions, as it may worsen symptoms 2

Transition to Oral Therapy

Switch to oral haloperidol as soon as practicable. Give the first oral dose within 12-24 hours following the last parenteral dose 1. Use the total 24-hour parenteral dose as an initial approximation for the oral daily dose, then adjust based on clinical response 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.